GlassScriptPhysician profile
Garnett Marcus Lowry
NPI 1790775690
$10,583.27
in general payments reported to CMS, 2019-2025
45 companies · $995 in 2025
The $995 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,955 · 2020: $1,134 · 2021: $1,612 · 2022: $1,730 · 2023: $1,092 · 2024: $2,066 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,152.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,790.57 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,349.56 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $787.73 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Janssen Pharmaceuticals, INC | $727.29 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $685.11 | 2019-2025 | Jardiance |
| Amgen INC. | $617.94 | 2019-2025 | Otezla, Repatha, Otezla |
| Merck Sharp & Dohme LLC | $442.66 | 2019-2024 | Verquvo, Belsomra, Gardasil |
| Abbvie INC. | $386.39 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $323.47 | 2021-2025 | |
| Esperion Therapeutics, INC. | $305.94 | 2020-2024 | Nexletol |
| Lightforce Orthodontics, INC. | $286.36 | 2024 | |
| Sanofi-Aventis U.S. LLC | $278.83 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $238.49 | 2019-2022 | |
| Pfizer INC. | $238.25 | 2019-2025 | |
| Glaxosmithkline, LLC. | $236.17 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garnett Lowry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.